SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : momo-T/FIF
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (11996)12/26/2018 3:21:01 PM
From: Ian@SI  Read Replies (1) of 12215
 
probably ACAD.

It's about $20 off its Nuplazid PDP (Parkinson's Disease Psychosis) high
since the CNN hit piece, even though the FDA has reconfirmed its approval
decision following a safety review.

Expanding the label to include ADP appears to be progressing favourably.

Not only would this greatly expand the demand, it may even convince some
of the non-scientists influenced by incompetent reporters. :-)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News